» Articles » PMID: 38816620

Robotic Versus Laparoscopic Pelvic Lateral Lymph Node Dissection in Locally Advanced Rectal Cancer: a Systemic Review and Meta-analysis

Overview
Journal Surg Endosc
Publisher Springer
Date 2024 May 30
PMID 38816620
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There are few available studies that compare the feasibility, efficacy, and safety of robotic pelvic lateral lymph node dissection compared to laparoscopic pelvic lateral lymph node dissection (LPLND) in advanced rectal cancer. This meta-analysis aims to compare perioperative outcomes between robotic and LPLND.

Methods: We performed a systemic literature review of PubMed, Embase, and Web of Science databases. Perioperative parameters were extracted and pooled for analysis. This meta-analysis provided an analysis of heterogeneity and prediction intervals.

Results: Five studies were included: 567 patients divided between 266 robotic and 301 LPLND. Overall operation time was longer in the robotic group than laparoscopic group (difference in means = 67.11, 95% CI [30.80, 103.42], p < 0.001) but the difference in the pelvic lateral lymph dissection time was not statistically significant (difference in means =  - 1.212, 95% CI [ - 11.594, 9.171], p = 0.819). There were fewer overall complications in the robotic than in the laparoscopic group (OR = 1.589, 95% CI [1.009, 2.503], p = 0.046), especially with respect to urinary retention (OR = 2.23, 95% CI [1.277, 3.894], p = 0.005). More pelvic lateral lymph nodes were harvested by robotic surgery than by laparoscopy (differences in means =  - 1.992, 95% CI [ - 2.421, 1.563], p < 0.001).

Conclusions: In this meta-analysis, robotic pelvic lateral lymph node dissection was associated with more pelvic lateral lymph nodes harvested and lower overall complications, especially urinary retention when compared to LPLND. Further studies are needed to reinforce these findings.

Citing Articles

Postoperative urinary dysfunction following lateral lymph node dissection for rectal cancer via minimally invasive surgery.

Takahashi M, Sakamoto K, Ro H, Kochi S, Toake M, Takahashi H BMC Surg. 2024; 24(1):416.

PMID: 39716123 PMC: 11664852. DOI: 10.1186/s12893-024-02697-5.


The role of lateral pelvic lymph node dissection in advanced rectal cancer: a review of current evidence and outcomes.

Choi G, Kim H Ann Coloproctol. 2024; 40(4):363-374.

PMID: 39228199 PMC: 11375230. DOI: 10.3393/ac.2024.00521.0074.

References
1.
Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S . Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol. 2013; 21(1):189-96. DOI: 10.1245/s10434-013-3216-y. View

2.
Kim M, Kim T, Kim D, Kim S, Baek J, Chang H . Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer?. J Surg Oncol. 2015; 111(4):459-64. DOI: 10.1002/jso.23852. View

3.
Bosset J, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L . Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006; 355(11):1114-23. DOI: 10.1056/NEJMoa060829. View

4.
Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y . Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2011; 17(1):1-29. DOI: 10.1007/s10147-011-0315-2. View

5.
Veldkamp R, Kuhry E, Hop W, Jeekel J, Kazemier G, Bonjer H . Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 2005; 6(7):477-84. DOI: 10.1016/S1470-2045(05)70221-7. View